OpinionPublished 28 Feb 2025
Advancements and Challenges in Clinical Trials for Gynecologic Cancer
Department of Gynecologic Oncology, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Gynecologic cancers, including ovarian, cervical, endometrial, vulvar, and vaginal malignancies, remain significant global health concerns despite advancements in early detection and treatment. Clinical trials play a crucial role in the development of innovative therapies, improving survival rates, and enhancing the quality of life for affected women. This article explores the various phases of clinical trials, the latest breakthroughs in targeted therapies and immunotherapy, and the challenges encountered in trial design, patient recruitment, and regulatory approvals. Furthermore, it highlights the importance of precision medicine and biomarker-driven trials in advancing personalized treatment strategies. By addressing these aspects, this review underscores the critical role of clinical research in shaping the future of gynecologic oncology.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInsights in Gynecologic Oncology
- SubjectOncology & Cancer
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Sonam Dema”